2021
DOI: 10.1016/j.bbadis.2021.166150
|View full text |Cite
|
Sign up to set email alerts
|

Cationic liposome-encapsulated carotenoids as a potential treatment for fibromyalgia in an animal model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
14
0
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(17 citation statements)
references
References 42 publications
1
14
0
2
Order By: Relevance
“…S2. Consistent with the above results, the content of MDA in βC and VE encapsulated liposomes was remarkably less than that in unloaded liposome (6.44 ± 0.09 nmol mL −1 ), indicating higher LPO‐inhibiting activities 51 . Co‐encapsulated liposomes showed a stronger LPO inhibition capability than L‐βC.…”
Section: Resultssupporting
confidence: 84%
See 1 more Smart Citation
“…S2. Consistent with the above results, the content of MDA in βC and VE encapsulated liposomes was remarkably less than that in unloaded liposome (6.44 ± 0.09 nmol mL −1 ), indicating higher LPO‐inhibiting activities 51 . Co‐encapsulated liposomes showed a stronger LPO inhibition capability than L‐βC.…”
Section: Resultssupporting
confidence: 84%
“…Consistent with the above results, the content of MDA in ⊎C and VE encapsulated liposomes was remarkably less than that in unloaded liposome (6.44 ± 0.09 nmol mL −1 ), indicating higher LPO-inhibiting activities. 51 Co-encapsulated liposomes showed a stronger LPO inhibition capability than L-⊎C. In particular, L-VE-⊎C at 5:3 and 3:1 significantly reduced the production of MDA, with a concentration of low to 0.80 ± 0.09 nmol mL −1better than single encapsulated liposomes.…”
Section: Lpo Assaymentioning
confidence: 86%
“…Nowadays, various methods are proposed to deliver carotenoids into the cytoplasmic membrane of the cells [ 71 , 72 , 73 , 74 , 75 ]. Yet, there is a lack of quantitative methods to evaluate the efficiency of the carotenoid delivery into the membrane.…”
Section: Discussionmentioning
confidence: 99%
“…The cationic liposomeencapsulated carotenoids (lutein or betacarotene) on a nanosized scale could be a good alternative to the pharmacological interventions for FM treatment. 80 Lutein inhibits IL-1-induced osteoclast differentiation and bone resorption, and lutein also inhibited the survival of mature osteoclasts in culture. When added to osteoblast culture, lutein enhances the formation of mineralized bone nodules by increasing BMP2 expression and inhibiting sclerotin expression.…”
Section: Bioactivity Of Luteinmentioning
confidence: 99%
“…Fibromyalgia (FM) is a chronic pain syndrome characterized by widespread pain in muscles and joints and chronic fatigue. The cationic liposome-encapsulated carotenoids (lutein or betacarotene) on a nanosized scale could be a good alternative to the pharmacological interventions for FM treatment . Lutein inhibits IL-1-induced osteoclast differentiation and bone resorption, and lutein also inhibited the survival of mature osteoclasts in culture.…”
Section: Bioactivity Of Luteinmentioning
confidence: 99%